Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses
- PMID: 2433388
- DOI: 10.1099/0022-1317-68-1-91
Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses
Abstract
Nineteen monoclonal antibodies produced to dengue type 4 virus (DEN-4) strain 4328-S were tested for their ability to mediate antibody-dependent infection enhancement (ADE) with seven DEN-2 strains in P-388D1 mouse macrophage-like cells. In this first study of the distribution of enhancing epitopes on multiple DEN-2 strains reacted with monoclonal antibodies to a different serotype (DEN-4), DEN-4 monospecific antibodies produced ADE with DEN-2 viruses, indicating the presence of DEN-4-like determinants on DEN-2 viruses. Analysis differentiated at least one and possibly more DEN-2 strain subgroups, one of which (isolates AHF-110 and AHF-191) was previously identified by DEN-2 monoclonal antibody analysis. The study demonstrates the heterogeneous distribution of dengue complex and DEN-4 epitopes on DEN-2 strains. Monoclonal antibodies are valuable tools for study of the biology of ADE and its relation to dengue shock syndrome.
Similar articles
-
Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.J Immunol. 1984 Mar;132(3):1529-32. J Immunol. 1984. PMID: 6607288
-
Study of the distribution of antibody-dependent enhancement determinants on dengue 2 isolates using dengue 2-derived monoclonal antibodies.J Med Virol. 1987 Jun;22(2):163-7. doi: 10.1002/jmv.1890220207. J Med Virol. 1987. PMID: 2440986
-
Topological mapping of unique epitopes on the dengue-2 virus NS1 protein using monoclonal antibodies.J Gen Virol. 1987 Mar;68 ( Pt 3):845-51. doi: 10.1099/0022-1317-68-3-845. J Gen Virol. 1987. PMID: 2434611
-
Pathogenesis of dengue: challenges to molecular biology.Science. 1988 Jan 29;239(4839):476-81. doi: 10.1126/science.3277268. Science. 1988. PMID: 3277268 Review.
-
Mechanisms of dengue virus-induced cell death.Adv Virus Res. 2003;60:157-86. doi: 10.1016/s0065-3527(03)60005-9. Adv Virus Res. 2003. PMID: 14689694 Review.
Cited by
-
V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1.Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11518-22. doi: 10.1073/pnas.90.24.11518. Proc Natl Acad Sci U S A. 1993. PMID: 7505441 Free PMC article.
-
A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies.Arch Virol. 1991;120(3-4):207-17. doi: 10.1007/BF01310476. Arch Virol. 1991. PMID: 1659798 Free PMC article.
-
Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II.J Virol. 2008 Jul;82(13):6631-43. doi: 10.1128/JVI.00316-08. Epub 2008 Apr 30. J Virol. 2008. PMID: 18448542 Free PMC article.
-
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient.Virol J. 2010 Feb 4;7:28. doi: 10.1186/1743-422X-7-28. Virol J. 2010. PMID: 20132551 Free PMC article.
-
A recombinant Fab neutralizes dengue virus in vitro.J Biotechnol. 1999 Apr 15;69(2-3):183-90. doi: 10.1016/s0168-1656(99)00037-1. J Biotechnol. 1999. PMID: 10361725 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources